已收盘 07-02 16:00:00 美东时间
+0.010
+0.91%
Artelo Biosciences reports positive preclinical data for ART26.12 in spinal cord injury neuropathic pain model Artelo reported positive preclinical data for ART26.12 in a mouse model of spinal cord injury-related neuropathic pain. Study showed reduced mechanical hypersensitivity, lower spontaneous p
07-01 20:42
Artelo Biosciences, Inc. (NASDAQ:ARTL) ("Artelo" or the "Company"), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological, or neurological conditions, announces that Myles Osborn, Lead Medicina...
06-10 19:40
Artelo Biosciences reports favorable human metabolite profile for ART26.12 in completed SAD trial Artelo Biosciences presented new human metabolite profiling results for pain candidate ART26.12 at a London DMPK and medicinal chemistry conference. Data came from plasma samples in a recently completed
06-10 19:38
-SEC Filing
05-27 04:55
Gainers: PHGE +97.3%, ARTL +74.8%, QTEX +52.4%, MNTX +34.4%, HLIT +28.3%, WOK +25%, CPSH +24.7%, CODX +22.7%, MDAI +22%. Losers: AKTX -25.2%, RYOJ -18.6%, DEVS -18.6%, AKAN -17%, ADTX -16.3%, LFS -15.6%
05-26 18:00
Wheeler房产投资信托涨-15.03%;康诺斯全球涨-11.28%;rYojbaba Co., Ltd.涨-11.00%
05-26 08:05
Gainers Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 635.6% to $2.0...
05-18 20:05
Liveramp Holdings Inc (NYSE: RAMP) rose in pre-market trading after being acquired by Publicis for $2.2 billion. Other gainers include SBFM, NXXT, GOVX, CREG, PMI, ZDAI, GCTS, CMPS, and DXYZ. BTM, EDBL, PIII, ARTL, and HCWB were among the losers.
05-18 17:38